ArticleFrontiers in oncology2024
A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases.
Falko Lange et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it